Short Pulse AntiRetroviral Therapy At human infection immunodeficiency virus (HIV) seroConversion: a Multicentre randomised trial of therapeutic intervention at primary HIV-1 infection.
Latest Information Update: 22 Jun 2021
At a glance
- Drugs Lamivudine/zidovudine (Primary) ; Lopinavir/ritonavir (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms SPARTAC
- 14 Jun 2021 Results assessing broadly neutralizing antibodies responses in 50 ART-naive individuals from control arm of the SPARTAC trial published in the AIDS
- 10 Mar 2021 Results evaluating a longitudinal analysis of the host transcriptome presented at the 28th Conference on Retroviruses and Opportunistic Infections.
- 17 Jan 2013 Results published in the New England Journal of Medicine.